|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02225 JINHAI MED-NEW
Nominal 
0.000 (0.000%) | 2023/12 - Final SGD(K$) | %Chg (Compare to Final) | 2022/12 SGD(K$) | 2021/12 SGD(K$) | 2020/12 SGD(K$) | 2019/12 SGD(K$) | |
| Turnover | 45,644 | 104.865% | 22,280 | 21,896 | 22,472 | 51,899 |
| Cost of Sales | (33,615) | 176.348% | (12,164) | (14,169) | (13,617) | (39,516) |
| Gross Profit | 12,029 | 18.911% | 10,116 | 7,727 | 8,855 | 12,383 |
| 2023/12 - Final SGD(K$) | %Chg (Compare to Final) | 2022/12 SGD(K$) | 2021/12 SGD(K$) | 2020/12 SGD(K$) | 2019/12 SGD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | (3,217) | -- | 784 | (62) | 1,426 | 86 | |
| Taxation | (895) | 33.982% | (668) | (435) | (163) | (771) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 971 | 175.852% | 352 | 252 | 0 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (3,141) | -- | 468 | (246) | 1,263 | (686) | |
| 2023/12 - Final SGD(K$) | %Chg (Compare to Final) | 2022/12 SGD(K$) | 2021/12 SGD(K$) | 2020/12 SGD(K$) | 2019/12 SGD(K$) | |
| Net Finance Costs / (Income) | 165 | 122.973% | 74 | 130 | 314 | 346 |
| Depreciation & Amortisation | 4,102 | -6.475% | 4,386 | 5,366 | 6,260 | 6,191 |
| Directors' Emoluments | 643 | -29.263% | 909 | 1,163 | 1,208 | 2,578 |
| 2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| EPS (cts) | -0.063 | -- | 0.010 | -0.005 | 0.025 | -0.015 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | (0.002) | -- | 0.003 | 0.003 | 0.006 | 0.006 |
| NBV per share ($) | 0.007248 | -- | 0.004953 | 0.004934 | 0.005181 | 0.004919 |
| Remarks: | Real time quote last updated: 27/12/2024 15:51 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders ($) | SGD -6,043,000 |
| %Change | -- |
| EPS / (LPS) | SGD -0.001 |
| NBV Per Share ($) | SGD 0.007 |